title: Burning mouth syndrome due to efavirenz therapy.
authors.forename: Joaquín
authors.initials: J
authors.lastname: Borrás-Blasco
authors.forename: Alberto
authors.initials: A
authors.lastname: Belda
authors.forename: J Dolores
authors.initials: JD
authors.lastname: Rosique-Robles
authors.forename: M D Elvira
authors.initials: MD
authors.lastname: Casterá
authors.forename: F Javier
authors.initials: FJ
authors.lastname: Abad
mesh_terms: D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects*; D048588:Benzoxazines; D002054:Burning Mouth Syndrome / Q000139:chemically induced*; D003521:Cyclopropanes; D005260:Female; D006801:Humans; D010078:Oxazines / Q000009:adverse effects*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz